Rho AI Software for Osteoporosis

Recruiting in Palo Alto (17 mi)

Overseen by James Bernatz, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Wisconsin, Madison

No Placebo Group

Trial Summary

What is the purpose of this trial?

To assess the effectiveness of 16bit's Rho AI (artificial intelligence) software at identifying known cases of osteoporosis. 800 de-identified images from January 2007 to January 2024 will be accessed to test the software prospectively.

Eligibility Criteria

This trial is for individuals with de-identified images from January 2007 to January 2024 that can be used to test the Rho AI software's ability to detect osteoporosis. Specific eligibility criteria are not provided.

Inclusion Criteria

Images from people who have undergone spine fusion

Images from people who have undergone total joint arthroplasty

Participant Groups

The study aims to validate the effectiveness of Rho AI software in identifying cases of osteoporosis using a set of 800 de-identified images collected over a period spanning from January 2007 to January 2024.

Group I: Experimental Detection of Osteoporosis Experimental Treatment 1 Intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

UW School of Medicine and Public Health Madison, WI

Who Is Running the Clinical Trial?

University of Wisconsin, Madison Lead Sponsor

References